Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial. (Q37350801)
Jump to navigation
Jump to search
scientific article published on 14 September 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial. |
scientific article published on 14 September 2015 |
Statements
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial (English)
George D Demetri
Martee L Hensley
Scott M Schuetze
Arthur Staddon
Anthony Elias
Kristen Ganjoo
Hussein Tawbi
Brian A Van Tine
Alexander Spira
Andrew Dean
Nushmia Z Khokhar
Youn Choi Park
Roland E Knoblauch
Trilok V Parekh
Shreyaskumar R Patel
Margaret von Mehren
14 September 2015
1 reference
1 reference
1 reference